Tsikouras P, Paraskevopoulos K, Bothou A et al (2020) Tongue cancer and pregnancy: report of two cases in association with HPV infection and literature review. Is HPV vaccination necessary to prevent of tongue cancer? J Syst Integr Neurosci 7

Peccatori FA, Azim HA Jr, Orecchia R et al (2013) Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):vi160–170

Article  PubMed  Google Scholar 

Silverstein J, Post AL, Chien AJ et al (2020) Multidisciplinary management of cancer during pregnancy. JCO Oncol Pract 16(9):545–557

Article  PubMed  Google Scholar 

Dalmartello M, Negri E, La Vecchia C (2020) Frequency of Pregnancy-Associated cancer: A systematic review of Population-Based studies 12(6)

Sung H, Ferlay J, Siegel RL, Global Cancer Statistics (2020) : GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries 71(3):209–249

Ng JH, Iyer NG, Tan MH, Edgren G (2017) Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study. Head Neck 39(2):297–304

Article  PubMed  Google Scholar 

Lloyd CJ, Paley MD, Penfold CN, Varadarajan V, Tehan B, Gollins SW (2003) Microvascular free tissue transfer in the management of squamous cell carcinoma of the tongue during pregnancy. Br J Oral Maxillofac Surg 41(2):109–111

Article  CAS  PubMed  Google Scholar 

Santos HB, dos Santos TK, Paz AR et al (2016) Clinical findings and risk factors to oral squamous cell carcinoma in young patients: A 12-year retrospective analysis. Med Oral Patol Oral Cir Bucal 21(2):e151–156

Article  PubMed  PubMed Central  Google Scholar 

MacMonegle AJ, Nonnemaker J, Duke JC et al (2018) Cost-Effectiveness analysis of the real cost campaign’s effect on smoking prevention. Am J Prev Med 55(3):319–325

Article  PubMed  Google Scholar 

Sakr Y, Hamdy O (2023) Shifting epidemiology trends in tongue cancer: A retrospective cohort study 15(23)

Sato K, Shimamoto H, Mochizuki Y et al (2019) Treatment of oral cancers during pregnancy: a case-based discussion. J Otolaryngol Head Neck Surg 48(1):9

Article  PubMed  PubMed Central  Google Scholar 

Eliassen AM, Hauff SJ, Tang AL et al (2013) Head and neck squamous cell carcinoma in pregnant women. Head Neck 35(3):335–342

Article  PubMed  Google Scholar 

Combes JD, Franceschi S (2014) Role of human papillomavirus in non-oropharyngeal head and neck cancers. Oral Oncol 50(5):370–379

Article  CAS  PubMed  Google Scholar 

Castellsagué X, Alemany L, Quer M et al (2016) HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Inst 108(6):djv403

Article  PubMed  Google Scholar 

Csurgay K, Zalatnai A, Benczik M et al (2021) A study of prognostic factors in young patients with Non-HPV oral cancer in central Europe. Pathol Oncol Res 27:1609991

Article  PubMed  PubMed Central  Google Scholar 

Christianto S, Li KY, Huang TH, Su YX (2022) The prognostic value of human papilloma virus infection in oral cavity squamous cell carcinoma: A Meta-Analysis. 132(9):1760–1770

Kareva I (2020) Immune suppression in pregnancy and cancer: parallels and insights. Transl Oncol 13(7):100759

Article  PubMed  PubMed Central  Google Scholar 

Muralidhara P, Sood V, Vinayak Ashok V, Bansal K (2022) Pregnancy and tumour: the parallels and differences in regulatory T cells. Front Immunol 13:2022–April

Article  Google Scholar 

Wegmann TG, Lin H, Guilbert L, Mosmann TR (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today. 14(7):353–356

Raghupathy R (1997) Th 1-type immunity is incompatible with successful pregnancy. Immunol. Today 18(10):478–482

Chaouat G, Ledée-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J (2004) TH1/TH2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/early abortion: reexamining the TH1/TH2 paradigm. Int Arch Allergy Immunol 134(2):93–119

Article  PubMed  Google Scholar 

Nevala WK, Vachon CM, Leontovich AA et al (2009) Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma. Clin Cancer Res 15(6):1931–1939

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shimato S, Maier LM, Maier R, Bruce JN, Anderson RC, Anderson DE (2012) Profound tumor-specific Th2 bias in patients with malignant glioma. BMC Cancer 12:561

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guenova E, Watanabe R, Teague JE et al (2013) TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma. Clin Cancer Res 15(14):3755–3763

Article  Google Scholar 

Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT (2004) Normal human pregnancy is associated with an elevation in the immune suppressive CD25 + CD4 + regulatory T-cell subset. Immunology 112(1):38–43

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ (2007) CD4 + CD25 + Foxp3 + regulatory T cells induce cytokine deprivation–mediated apoptosis of effector CD4 + T cells. Nat Immunol 8(12):1353–1362

Article  CAS  PubMed  Google Scholar 

Sitrin J, Ring A, Garcia KC, Benoist C, Mathis D (2013) Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2. J Exp Med 210(6):1153–1165

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gasteiger G, Hemmers S, Firth MA et al (2013) IL-2–dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells. J Exp Med 210(6):1167–1178

Article  CAS  PubMed  PubMed Central  Google Scholar 

Read S, Malmström V, Powrie F (2000) Cytotoxic T lymphocyte–associated antigen 4 plays an essential role in the function of Cd25 + Cd4 + regulatory cells that control intestinal inflammation. J Exp Med 192(2):295–302

Article  CAS  PubMed  PubMed Central  Google Scholar 

Read S, Greenwald R, Izcue A et al (2006) Blockade of CTLA-4 on CD4 + CD25 + regulatory T cells abrogates their function in vivo. J Immunol 177(7):4376–4383

Article  CAS  PubMed  Google Scholar 

Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S (2004) Decidual and peripheral blood CD4 + CD25 + regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 10(5):347–353

Article  CAS  PubMed  Google Scholar 

Whiteside TL (2015) The role of regulatory T cells in cancer immunology. Immunotargets Ther 4:159–171

Article  PubMed  PubMed Central  Google Scholar 

Shang B, Liu Y, Jiang S-j, Liu Y (2015) Prognostic value of tumor-infiltrating FoxP3 + regulatory T cells in cancers: a systematic review and meta-analysis. Sci Rep 5(1):15179

Article  CAS  PubMed  PubMed Central  Google Scholar 

Enninga EA, Nevala W, Creedon D, Flotte T, Dong H, Markovic S (2016) Shared immunoregulatory properties of galectin-9 and PD-L1 in pregnant women and patients with stage IV melanoma. Placenta 45:86–87

Article  Google Scholar 

Enninga EA, Nevala WK, Holtan SG, Leontovich AA, Markovic SN (2016) Galectin-9 modulates immunity by promoting Th2/M2 differentiation and impacts survival in patients with metastatic melanoma. Melanoma Res 26(5):429–441

Article  CAS  PubMed  PubMed Central  Google Scholar 

Enninga EAL, Harrington SM, Creedon DJ et al (2018) Immune checkpoint molecules soluble program death ligand 1 and galectin-9 are increased in pregnancy. Am J Reprod Immunol 79(2)

Aghaeepour N, Ganio EA (2017) An immune clock of human pregnancy. 2(15)

Markou E, Eleana B, Lazaros T, Antonios K (2009) The influence of sex steroid hormones on gingiva of women. The Open Dentistry J 3:114–119

Article  CAS  Google Scholar 

Balan U, Gonsalves N, Jose M, Girish KL (2012) Symptomatic changes of oral mucosa during normal hormonal turnover in healthy young menstruating women. J Contemp Dent Pract 13(2):178–181

Article  PubMed  Google Scholar 

Välimaa H, Savolainen S, Soukka T et al (2004) Estrogen receptor-beta is the predominant Estrogen receptor subtype in human oral epithelium and salivary glands. J Endocrinol 180(1):55–62